Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
This study has been completed.
Study NCT00240318.   Last updated on May 2, 2006.
Information provided by AstraZeneca
Please refer to this study by its ClinicalTrials.gov identifier: NCT00240318
Locations
United States, Alabama
Research Site
Birmingham, Alabama, United States
United States, California
Research Site
Los Angeles, California, United States
Research Site
San Francisco, California, United States
Research Site
Santa Rosa, California, United States
Research Site
Stockton, California, United States
United States, Colorado
Research Site
Denver, Colorado, United States
United States, Connecticut
Research Site
Hartford, Connecticut, United States
United States, Florida
Research Site
Atlantis, Florida, United States
United States, Illinois
Research Site
Chicago, Illinois, United States
Research Site
Maywood, Illinois, United States
United States, Maine
Research Site
Auburn, Maine, United States
United States, Maryland
Research Site
Baltimore, Maryland, United States
United States, Michigan
Research Site
Ann Arbor, Michigan, United States
Research Site
Petoskey, Michigan, United States
United States, Minnesota
Research Site
Minneapolis, Minnesota, United States
Research Site
St. Paul, Minnesota, United States
United States, New York
Research Site
Buffalo, New York, United States
Research Site
Valhalla, New York, United States
Research Site
Williamsville, New York, United States
United States, North Carolina
Research Site
Chapel Hill, North Carolina, United States
United States, Ohio
Research Site
Toledo, Ohio, United States
United States, Pennsylvania
Research Site
Danville, Pennsylvania, United States
United States, Texas
Research Site
Houston, Texas, United States
United States, Wisconsin
Research Site
Milwaukee, Wisconsin, United States
Australia
Research Site
Auchenflower, Australia
Research Site
Clayton, Australia
Research Site
Heidelberg, Australia
Research Site
New Lambton, Australia
Belgium
Research Site
Aalst, Belgium
Research Site
Bruxelles, Belgium
Research Site
Edegem, Belgium
Research Site
Liege, Belgium
Canada, Nova Scotia
Research Site
Halifax, Nova Scotia, Canada
Canada, Quebec
Research Site
Montreal, Quebec, Canada
Research Site
Ste-Foy, Quebec, Canada
France
Research Site
Massy, France
Research Site
Limoges, France
Research Site
Lyon, France
Research Site
Creteil, France
Research Site
Melun, France
Research Site
Paris, France
Research Site
Pessac, France
Research Site
Toulouse, France
Italy
Research Site
Pisa, Italy
Research Site
Milan, Italy
Research Site
Pavia, Italy
Research Site
Genova, Italy
Research Site
Rome, Italy
Research Site
Rome, Italy
Research Site
Siena, Italy
Research Site
Udine, Italy
Italy, Milan
Research Site
Rozzano, Milan, Italy
Italy, Venezia
Research Site
Mirano, Venezia, Italy
Netherlands
Research Site
Amsterdam, Netherlands
Research Site
Maastricht, Netherlands
Research Site
Nieuwegein, Netherlands
Research Site
Zwolle, Netherlands
Spain
Research Site
Barcelona, Spain
Research Site
Madrid, Spain
Research Site
Valladolid, Spain
Research Site
Murias, Spain
Research Site
Malaga, Spain
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: AstraZeneca Crestor Medical Sciences Director, MD AstraZeneca